Introduction
Atrial fibrillation (AF) is one of the most frequently occurring arrhythmias, and projections have shown that the number of adults with AF will increase. The prevalence of AF in Europe may reach 17.9 million people in 2060 1 and the prevalence in the USA may reach 15.9 million people in 2050. 2 Several risk factors for AF have been identified, many of which are also risk factors for coronary calcification, including increasing age, sex, systolic blood pressure, body mass index (BMI), hypertension, and diabetes mellitus. cardiac computed tomography (nCCT) and the Agatston score method 6 for measuring the coronary artery calcium score (CACS) has identified CACS as a compelling predictor of future cardiovascular events, including cardiovascular death, and all-cause mortality. [7] [8] [9] CACS also has a potential as a biomarker for the development of non-cardiovascular events such as cancer, chronic kidney disease, chronic obstructive pulmonary disease, and hip fractures. 10 Recently, CACS was introduced as a novel independent risk factor for AF based on results reported by the Multi-Ethnic Study of Atherosclerosis.
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Gaining more insight into the role of CACS in relation to the risk of future AF is of major clinical relevance. First, more accurate identification of individuals at high risk for AF may facilitate a stronger focus on disease prevention and, in particular, interventions indented to address modifiable risk factors. Secondly, stroke is a well-known complication of AF that can be effectively prevented using oral anticoagulant therapy. 12 However, as many as 40% of patients with AFrelated strokes are not diagnosed with AF until they have a stroke. 13 Thus, earlier detection of AF may lead to improvements in AF care and contribute to reductions in the number of AF-related stroke episodes.
Identifying CACS as a biomarker for the development of AF may consequently have important clinical and public health implications. Therefore, in this study with a longitudinal design, we examined the association between CACS and development of AF and the predictive accuracy of CACS in a large cohort of patients who underwent nCCT for the indication of suspected coronary artery disease (CAD).
Methods

Design and population
We conducted a registry-based cohort study involving patients in Western Denmark who were suspected of CAD. We defined baseline as the time at which these patients had their CACS measured using nCCT between January 2010 and September 2015. Patients were identified from the Western Denmark Heart Registry, a validated clinical quality database covering Western Denmark, whose population comprises approximately 3.3 million people. 14, 15 It is an encrypted online data management system that uses the Civil Registration number as the key identifier. Staff members examining patients for CAD enter data into the system from each individual cardiac centre. Information regarding referral, medical history, and procedure are reported for each procedure. We used information from the first procedure for patients who underwent multiple procedures during the study period. All Danish citizens are assigned a unique 10-digit Civil Registration number enabling unambiguous linkages between public registers. The Civil Registration System contains individual information pertaining to sex and place of residence, as well as information on vital statistics and migration that is updated daily. 16 The following conditions led to exclusion before the nCCT: invalid Civil Registration number, invalid municipality, and residency in a municipality in Greenland. Furthermore, we excluded individuals with a history of valvular disease (mitral stenosis or mechanical prosthetic heart valve), 17 acute myocardial infarction, percutaneous coronary intervention (PCI), heart surgeries such as coronary artery bypass grafting (CABG), CAD, and AF (including atrial flutter), as well as patients with missing CACS. The final study population consisted of 27 962 patients. Figure 1 shows the full flowchart.
Measurement of CACS
CACSs were measured using electrocardiography-triggered nCCT and the Agatston score method. 6 Coronary calcium lesions were defined as having a threshold > _ 130 Hounsfield units (HUs) and an area > _ 1 mm 2 . The products of the area of each calcified plaque and peak HU, defined as 1 (130-199 HUs), 2 (200-299 HUs), 3 (300-399 HUs), and 4 (> _400 HUs), were summed for the left main coronary artery, left anterior descending coronary artery, left circumflex coronary artery, and right coronary artery to determine the total CACS. During the study period, the different centres used the following scanner types: Dual source Siemens Somatom Sensation 64 CT Scanner, Philips Brilliance 64 CT scanner, Philips Brilliance 256 CT, GE LightSpeed VCT 64, Toshiba Aquilion 64, Toshiba Aquilion ONE 320, Siemens Somatom Definition Flash, and GE Discovery CT750 HD. Inter-and intrascan reproducibility of CACS measurement 18, 19 and intraobserver or interobserver variation have been reported to be excellent. 20 Ascertainment of new-onset AF 22, 23 corresponding to a high probability of having AF or atrial flutter according to information recorded in the medical record. Only approximately 5% of ICD-10 I48 diagnoses correspond to atrial flutter. 23 Death and migration led to censoring but death was also considered a competing risk.
Covariates
We identified prior acute myocardial infarction, prior PCI, prior heart surgery, BMI (computed from height and weight), diabetes mellitus, heart failure (ejection fraction < 40%), hypertension (defined as receiving antihypertensive medication), smoking status, systolic and diastolic blood pressure, lipid-lowering treatment reception, and CACS from the Western Denmark Heart Registry. We identified valvular disease (ICD-10: I050, I052, I342, procedure code for mistral stenosis surgery, or mechanical valve implantation), CAD (ICD-10: I21-I25), AF (and atrial flutter) (ICD-10: I48), stroke/transient ischaemic attack/systemic embolism (ICD-10: I60-I64, I74, G45 without G45.3), and CABG from the Danish National Patient Registry. We identified acute myocardial infarction (ICD-10: I21-I22), PCI, heart surgery, hypertension (I10-I13, I15), diabetes mellitus (E10-E11), and heart failure (I50) from the National Patient Registry when information was missing from the Western Danish Heart Registry.
Age at nCCT and sex were determined using the Civil Registration System.
Ethics
The Danish Data Protection Agency approved the study (1-16-02-77-13). Registry-based studies do not require approval from an ethics committee in Denmark according to Danish law.
Statistical analysis
CACS was examined both as a categorical (0, 1-99, 100-399, 400-999, and > _1000) and as a continuous variable (log 2 [CACS þ 1]). Log 2 (CACS þ 1) increases by one when CACS þ 1 doubles. We used the Aalen-Johansen estimator to compute adjusted cumulative incidence of AF by CACS group using time from nCCT as the timescale, with death as a competing risk. Missing data were considered missing at random. We used multiple imputations by chained equations to replace missing values for BMI, smoking status, systolic blood pressure, diastolic blood pressure, and lipid-lowering treatment reception. The imputed values were based on information pertaining to all variables included in the analysis model and a censoring/event indicator. Imputed values were used to complete Models 2 and 3. We created 20 imputed datasets to reduce sampling variability from the imputation process.
Hazard ratios (HRs) for CACS were estimated using Cox proportional hazards regression, using age as the underlying timescale, corresponding to an adjustment for age in all analyses. The proportionality assumption of the Cox model was evaluated using log-log plots for survival and the assumption was not violated. HRs were estimated with 95% confidence intervals (CI). CACSs of 0 were defined as the reference group when CACSs were analysed as a categorical variable. We applied four models in the regression analysis, including an unadjusted model that was adjusted only for age (timescale). In Model 1, we adjusted for sex. In Model 2, we also adjusted for BMI, systolic, and diastolic blood pressure as continuous variables; smoking status as a categorical variable; and diabetes mellitus, heart failure, lipid-lowering medication reception, antihypertensive medication reception, and prior stroke/transient ischaemic attack/ systemic embolism as dichotomous variables. Model 3 included Model 2 and CABG as a time-dependent covariate. We tested for interactions between sex and CACS as a categorical and continuous variable.
All analyses were performed using STATA version 14.2, College Station, TX, USA. Table 1 presents the baseline characteristics of the entire study cohort. The mean age was 56.9 years and 44.6% of the patients were males. Of the 27 962 patients, 52.2% had a CACS of 0; 25.7% had a CACS of 1-99; 12.6% had a CACS of 100-399; 5.9% had a CACS of 400-999; and 3.7% had a CACS > _ 1000. Table 2 shows the baseline characteristics of the patients stratified by CACS group after multiple imputations. We found that a high CACS was associated with high age, a high proportion of men, and a high proportion of former or current smokers. Consistent with this finding, less severe coronary calcification was observed among nonsmokers. A high CACS was significantly more likely to be found among patients with diabetes mellitus, heart failure, hypertension, hyperlipidaemia, and prior stroke/transient ischaemic attack/systemic embolism.
Results
Baseline characteristics
The risk of AF
During a median follow-up of 2.9 (interquartile range 1.6-4.2) years and a total time at risk of 83 001 years, 622 patients were diagnosed with AF, corresponding to an overall incidence of 7.5 (95% CI: 6.9-8.1) per 1000 person-years. When comparing the incidence rates of AF according to CACS (Table 3) , we found that the incidence increased from 4.5 (95% CI: 3.9-5.2) among patients with a CACS of 0 to 23.8 (95% CI: 18.7-30.2) among patients with a CACS > _ 1000 per 1000 person-years. Figure 2 shows the cumulative incidence of AF, and we noted the following cumulative incidence of AF 4 years after nCCT, according to CACS group: CACSs of 0: 1.77% (95% CI: 1.52-2.05), CACSs of 1-99: 2.54% (95% CI: 2.09-3.06), CACSs of 100-399: 4.48% (95% CI: 3.66-5.42), CACSs of 400-999: 6.92% (95% CI: 5.46-8.60), and CACSs > _ 1000: 7.76% (95% CI: 5.96-9.86). For CACSs > _ 1000, we observed a very sharp increase in the cumulative incidence of AF during first three months after nCCT.
We performed an unadjusted analysis and noted that the risk of AF increased as the CACS category increased ( Table 4) . When the CACS doubled, the HR was 1.07 (95% CI: 1.05-1.10). When adjusting for sex in Model 1, the overall association between CACS and the risk of AF remained virtually unchanged. In the fully adjusted Model 3, the HRs remained unchanged and thus appeared robust under the influence of confounding factors. The HRs for each CACS category were as follows: CACSs of 1-99: 1.00 (95% CI: 0.80-1.25); CACSs of 100-399: 1.36 (95% CI: 1.06-1.74); CACSs of 400-900: 1.76 (95% CI: 1.33-2.35); CACSs > _ 1000: 1.67 (95% CI: 1.20-2.34). In the fully adjusted Model 3, the HR was 1.05 (95% CI: 1.03-1.08) when the CACS doubled.
In a subanalysis, we excluded patients with a history of stroke/transient ischaemic attack/systemic embolism before baseline. However, the results showed no substantial difference (results not shown).
Using Model 3, we tested for interactions between CACS group and sex (P = 0.59) and log 2 (CACS þ 1) and sex (P = 0.82) and noted no interactions. 
Predictive accuracy of CACS
We examined the post-test probability of developing AF within 1 year after nCCT according to CACS. Figure 3 presents an ROC curve for the post-test probability of developing AF according to log 2 (CACS þ 1). We found an area under the curve (AUC) of 0.68 (95% CI: 0.65-0.71), which was not substantially different between men and women.
We applied cut-off values according to the CACS groups ( Table 5) . When using a CACS of 0 as cut-off, we found that 73.1% of patients who developed AF during the first year after nCCT had a CACS > 0, and that 52.7% of patients who did not develop AF during first year after nCCT had a CACS of 0. These data indicate that 1.6% of patients with CACS > 0 developed AF during the first year after nCCT and that 99.4% of patients with a CACS of 0 did not develop AF during the first year. Table 5 shows the results for all of the defined cut-offs.
Discussion
In this large registry-based cohort study of patients suspected of having CAD who underwent nCCT, we demonstrated that a high CACS was associated with a high risk of AF and that the relationship between the two parameters was such that an individual's risk of AF increased as the CACS increased, even after multivariable adjustment. We also demonstrated that CACS had moderate predictive accuracy with respect to identifying individuals at risk for developing AF within one year after nCCT.
We found that the relationship between CACS and AF is not attributable to the most common risk factors for AF because our models included the most relevant and accessible risk factors and potential confounders. Our study results are consistent with findings from the Multi-Ethnic Study of Atherosclerosis by O'Neal et al., 11 which, to our knowledge, is the only other study on this specific topic We adjusted for age (as timescale) in all analyses. Model 1: Adjusted for sex. Model 2: Adjusted as in Model 1 and for BMI, smoking status, diabetes mellitus, systolic blood pressure, diastolic blood pressure, heart failure, lipid-lowering medical treatment, medical treatment for hypertension, and prior stroke/transient ischaemic attack/systemic embolism. Model 3: Adjusted as in Model 2 and for CABG (n = 508) during follow-up (time-dependent exposure). 11 Unequal confounder distribution may partially account for the discrepancy between the studies. For instance, the present study cohort was younger and consisted of fewer men than the aforementioned study. We based our AF ascertainments on registries containing complete follow-up information, independent of the facilities to which patients were admitted. Furthermore, we used age as the underlying timescale in our analyses because of the strong association between age and AF. In contrast to O'Neal et al., 11 we noted a sharp increase in the cumulative incidence in patients with CACSs > _ 1000, probably because a high CACS is associated with a high revascularization rate, and CABG, which is performed for revascularization, is known to be associated with a high risk of AF. The exact pathogenic processes explaining how patients progress from coronary calcification to AF are not clear. Several mechanisms underlying the relationship between coronary obstruction/occlusion and risk of AF have been suggested. CAD, which is correlated with the CACS, 24 is associated with low-grade subclinical inflammation, and ischaemia or atrial myocardial infarction is associated with a healing process that triggers myocardial damage and atrial inflammation. 25, 26 Inflammatory mediators seem to alter electrical and structural remodelling and thus trigger AF. Additionally, inflammation also seems to play a role in post-operative AF, for example, AF after CABG. 26 Furthermore, it has been shown that the extent of CACS progression may be an important factor in the relationship between CACS and AF. 27 The relationship between CACS and AF may also be explained by the fact that a high CACS is associated with dilated pulmonary veins and a larger left atrium, which have the potential to initiate and perpetuate atrial re-entrant circuits. 28 Our results may have long-term clinical implications. We noted a moderate AUC when using CACS as a tool for predicting AF. Hence, CACSs should be interpreted in connection with patient risk profiles. Adding CACS to risk scores from the Framingham Heart Study and Aging Research in Genomic Epidemiology (CHARGE)-AF improves the AUC with respect to predicting AF. 11 Using CACS in combination with knowledge of other risk factors makes it possible to identify patients at high risk for AF, in whom the tolerance of modifiable AF risk factors should be set at an even lower level than in patients not at high risk of AF, and disease prevention efforts should be more aggressive. Accordingly, using CACS in combination with knowledge regarding other AF risk factors will enable AF prevention and earlier treatment start-up in patients who most likely develop AF and thus reduce the number of incident strokes among these patients. Given that the number of patients with AF is increasing, this potential improvement in early AF detection may ultimately benefit more patients and have important public health consequences. However, additional studies are needed to examine the usefulness of CACS for stroke reduction in AF patients.
The main strengths of our study were its use of a population-based method, its large population size, and its application of prospectively collection of data. Additionally, this study was strengthened by the fact that it utilized the Western Denmark Heart Registry, whose data are characterized by a high degree of completeness and validity, 14 and that it uses Danish registers to ensure that patient follow-up was complete. Migration bias was unlikely because patient migration status is recorded in the Civil Registration System. The diagnosis of AF in the National Patient Registry has been found to have a high positive predictive value. 23 Patients enrolled in this study do not represent the general population, as they were suspected of having CAD. According to a report from the Western Denmark Heart Registry 2014, 58% of patients undergoing nCCT do not have diseased vessels, and nCCT does not lead to consequences in terms of treatment in 63% of patients. Using data on antiarrhythmic medication as exclusion may have excluded patients with AF before baseline more accurately; unfortunately, those data were unavailable. Differential misclassification may occur if patients with a high CACS are followed more carefully than patients with a CACS of 0, which may lead to a higher likelihood of being diagnosed with AF. It is possible that differences may exist in the way the CACSs were measured, which could have introduced some misclassification, most likely of a non-differential nature. It should also be stressed that our finding of CACS being a predictor of AF does not imply causality. We were not able to distinguish between persistent, permanent, and paroxysmal AF; therefore, paroxysmal AF might be underreported. Furthermore, residual confounding is possible, for instance, with respect to categorizing smoking, and a lack of information on potential confounders, such as ethnicity and alcohol consumption, may lead to imprecision.
Conclusions
A high CACS is associated with a high risk of AF. CACS combined with knowledge regarding other AF risk factors may help clinicians to identify patients at high risk for AF, which may facilitate both disease prevention and earlier treatment of patients who most likely develop AF and thus reduce their risk of stroke.
